Medical Science Liaison

About Quetzal Therapeutics LLC Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also developing a pre-clinical asset QTX-2102, an advanced, next-generation antifungal and antiparasitic therapy designed to enhance efficacy while minimizing toxicity. Our mission is to push the boundaries of treatment possibilities, delivering hope and life-changing solutions to those who need them most. Contractor Medical Science Liaison (MSL) - Italy/Germany Territory Haematology / Oncology - Phase 3 Clinical Trial Support Role Overview We are seeking an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology clinical trial across Italy and Germany. This field-based role will focus on scientific engagement with investigators and treatment centres, supporting trial awareness, operational engagement, and high-quality scientific exchange within a compliant framework. The successful candidate will work independently across a geographically distributed territory and act as a key scientific interface between the company and external stakeholders. Territory Coverage Italy Germany Travel within the assigned territory and attendance at relevant scientific meetings/congresses will be required. Time in Field Approximately 70-80% field-focused activity expected. Key Responsibilities Develop and maintain scientific relationships with investigators, referral centres, and relevant healthcare professionals Support scientific engagement around an ongoing Phase 3 haematology clinical trial Deliver high-quality, non-promotional scientific exchange in compliance with applicable regulations and company SOPs Support trial awareness and operational engagement activities within assigned territories Identify and communicate field insights, including recruitment challenges, treatment landscape developments, and investigator feedback Support congress activities, investigator meetings, and scientific discussions as required Ensure timely and accurate documentation of activities and reporting of adverse events/product complaints in accordance with pharmacovigilance requirements Work cross-functionally with Medical Affairs, Clinical Operations, and other internal stakeholders Required Qualifications & Experience Advanced scientific or healthcare degree (PharmD, PhD, MD, MSc or equivalent) Prior experience as a field-based MSL within oncology or haematology Strong scientific acumen and ability to communicate complex clinical data effectively Demonstrated ability to work independently across a multi-site territory Experience developing relationships with academic investigators and healthcare professionals Strong communication, presentation, and stakeholder engagement skills Experience working within GCP, pharmacovigilance, and compliance frameworks Fluent English Experience within Italy and/or Germany is essential Strongly Preferred Italian language proficiency strongly preferred Prior experience in haematology and/or rare cancers Experience supporting Phase 2 or Phase 3 clinical trials Experience supporting recruitment or referral engagement activities for clinical trials Existing relationships within relevant haematology treatment centres Experience working in multinational European territories Working Model Contractor / consultancy engagement Field-based role Travel required across assigned territories #J-18808-Ljbffr